<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3077">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01437501</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00003494</org_study_id>
    <secondary_id>5P01ES006052</secondary_id>
    <nct_id>NCT01437501</nct_id>
  </id_info>
  <brief_title>Broccoli Sprout Intervention in Qidong, P.R. China</brief_title>
  <official_title>Broccoli Sprout Intervention in Qidong, P.R. China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins Bloomberg School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Environmental Health Sciences (NIEHS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qidong Liver Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins Bloomberg School of Public Health</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a 12 week placebo-controlled Phase II broccoli sprout intervention to be
      conducted in Qidong, P.R. China. One thousand two hundred people from the farming townships
      will be screened and three hundred eligible individuals will be enrolled in the study.
      Participants will be randomized into two treatment groups: one will receive a juice beverage
      containing glucoraphanin- and sulforaphane-rich broccoli sprout extract, pineapple juice,
      lime juice, and water and the other will receive a placebo beverage containing pineapple
      juice, lime juice and water. Participants will drink their assigned beverage every evening
      and provide biweekly urine samples and monthly blood samples. The principal endpoints of
      this study are pharmacokinetic evaluation of elimination of glucoraphanin/sulforaphane and
      their metabolites in urine and pharmacodynamic evaluation through measures of urinary levels
      of exposure biomarkers for dietary and air-borne toxins, which are known to be high in this
      population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Effect of Treatment on Levels of Air Toxics Mercapturic Acids Over Intervention Period</measure>
    <time_frame>Endpoints were assessed on urine samples collected at the end of the intervention on week 12.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Urinary excretion of benzene mercapturic acid (S-PMA) in 12 hour overnight void at 12 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Levels of Glucoraphanin/Sulforaphane and Their Metabolites Over Intervention Period</measure>
    <time_frame>Endpoints assessed on urine and blood samples collected during the intervention on weeks 0, 1, 2, 4, 6, 8, 10 and 12.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">291</enrollment>
  <condition>Environmental Carcinogenesis</condition>
  <arm_group>
    <arm_group_label>Broccoli Sprout Extract Beverage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo beverage</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Broccoli Sprout Extract Beverage</intervention_name>
    <description>Broccoli Sprout Extract Beverage: 600 micromole glucoraphanin and 40 micromole sulforaphane dissolved in 100 mL dilute pineapple and lime juice daily for 84 days.</description>
    <arm_group_label>Broccoli Sprout Extract Beverage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo beverage</intervention_name>
    <description>100 mL of dilute pineapple and lime juice daily for 84 days.</description>
    <arm_group_label>Placebo beverage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 21-65 years

          -  in good general health with no history of chronic illness

          -  normal liver function tests: alanine aminotransferase (ALT), aspartate
             aminotransferase (AST), bilirubin)

          -  normal renal function tests (creatinine, blood urea nitrogen, urinalysis)

          -  serum alpha-fetoprotein negative

        Exclusion Criteria:

          -  personal history of cancer except for non-melanoma skin cancer

          -  use of prescribed medications

          -  hepatomegaly by clinical exam

          -  for women, a positive pregnancy test
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas W Kensler, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins Bloomberg School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Qidong Liver Cancer Institute</name>
      <address>
        <city>Qidong</city>
        <state>Jiangsu</state>
        <zip>226200</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Kensler TW, Chen JG, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, Ye L, Coady JL, Wang JB, Wu Y, Sun Y, Zhang QN, Zhang BC, Zhu YR, Qian GS, Carmella SG, Hecht SS, Benning L, Gange SJ, Groopman JD, Talalay P. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2605-13.</citation>
    <PMID>16284385</PMID>
  </reference>
  <reference>
    <citation>Egner PA, Chen JG, Wang JB, Wu Y, Sun Y, Lu JH, Zhu J, Zhang YH, Chen YS, Friesen MD, Jacobson LP, Mu√±oz A, Ng D, Qian GS, Zhu YR, Chen TY, Botting NP, Zhang Q, Fahey JW, Talalay P, Groopman JD, Kensler TW. Bioavailability of Sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prev Res (Phila). 2011 Mar;4(3):384-95. doi: 10.1158/1940-6207.CAPR-10-0296.</citation>
    <PMID>21372038</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 19, 2013</lastchanged_date>
  <firstreceived_date>September 15, 2011</firstreceived_date>
  <firstreceived_results_date>May 2, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins Bloomberg School of Public Health</investigator_affiliation>
    <investigator_full_name>Thomas Kensler</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>glucoraphanin</keyword>
  <keyword>sulforaphane</keyword>
  <keyword>pharmacokinetics</keyword>
  <keyword>pharmacodynamics</keyword>
  <keyword>broccoli sprout</keyword>
  <keyword>carcinogens, environment</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinogenesis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>1205 Individuals were recruited from HeHe Township in Qidong, PRC for eligibility screening at 3 medical clinics within the township in September 2011.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Broccoli Sprout Extract Beverage</title>
          <description>Broccoli Sprout Extract Beverage : Broccoli Sprout Extract Beverage: 600 micromole glucoraphanin and 40 micromole sulforaphane dissolved in 100 mL dilute pineapple and lime juice daily for 84 days.</description>
        </group>
        <group group_id="P2">
          <title>Placebo Beverage</title>
          <description>placebo beverage : 100 mL of dilute pineapple and lime juice daily for 84 days.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="148"/>
                <participants group_id="P2" count="143"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="135"/>
                <participants group_id="P2" count="132"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Broccoli Sprout Extract Beverage</title>
          <description>Broccoli Sprout Extract Beverage : Broccoli Sprout Extract Beverage: 600 micromole glucoraphanin and 40 micromole sulforaphane dissolved in 100 mL dilute pineapple and lime juice daily for 84 days.</description>
        </group>
        <group group_id="B2">
          <title>Placebo Beverage</title>
          <description>placebo beverage : 100 mL of dilute pineapple and lime juice daily for 84 days.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="148"/>
                <measurement group_id="B2" value="143"/>
                <measurement group_id="B3" value="291"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="148"/>
                <measurement group_id="B2" value="143"/>
                <measurement group_id="B3" value="291"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="51.1" spread="9.4"/>
                <measurement group_id="B2" value="52.6" spread="7.7"/>
                <measurement group_id="B3" value="51.8" spread="8.7"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="118"/>
                <measurement group_id="B2" value="111"/>
                <measurement group_id="B3" value="229"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="30"/>
                <measurement group_id="B2" value="32"/>
                <measurement group_id="B3" value="62"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>China</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="148"/>
                <measurement group_id="B2" value="143"/>
                <measurement group_id="B3" value="291"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effect of Treatment on Levels of Air Toxics Mercapturic Acids Over Intervention Period</title>
        <description>Urinary excretion of benzene mercapturic acid (S-PMA) in 12 hour overnight void at 12 weeks</description>
        <time_frame>Endpoints were assessed on urine samples collected at the end of the intervention on week 12.</time_frame>
        <safety_issue>No</safety_issue>
        <population>Analyses were conducted on all urine samples provided by study participants at week 12.</population>
        <group_list>
          <group group_id="O1">
            <title>Broccoli Sprout Extract Beverage</title>
            <description>Broccoli Sprout Extract Beverage : Broccoli Sprout Extract Beverage: 600 micromole glucoraphanin and 40 micromole sulforaphane dissolved in 100 mL dilute pineapple and lime juice daily for 84 days.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Beverage</title>
            <description>placebo beverage : 100 mL of dilute pineapple and lime juice daily for 84 days.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="135"/>
                  <measurement group_id="O2" value="132"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Effect of Treatment on Levels of Air Toxics Mercapturic Acids Over Intervention Period</title>
            <description>Urinary excretion of benzene mercapturic acid (S-PMA) in 12 hour overnight void at 12 weeks</description>
            <units>pmol/mg creatinine</units>
            <param>Median</param>
            <dispersion>Inter-Quartile Range</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1.700" lower_limit="1.235" upper_limit="2.386"/>
                  <measurement group_id="O2" value="1.065" lower_limit="0.686" upper_limit="1.826"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Levels of Glucoraphanin/Sulforaphane and Their Metabolites Over Intervention Period</title>
        <time_frame>Endpoints assessed on urine and blood samples collected during the intervention on weeks 0, 1, 2, 4, 6, 8, 10 and 12.</time_frame>
        <safety_issue>No</safety_issue>
        <posting_date>01/2014</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Broccoli Sprout Extract Beverage</title>
          <description>Broccoli Sprout Extract Beverage : Broccoli Sprout Extract Beverage: 600 micromole glucoraphanin and 40 micromole sulforaphane dissolved in 100 mL dilute pineapple and lime juice daily for 84 days.</description>
        </group>
        <group group_id="E2">
          <title>Placebo Beverage</title>
          <description>placebo beverage : 100 mL of dilute pineapple and lime juice daily for 84 days.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="148"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="143"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.3</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="148"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="143"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>light vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="143"/>
              </event>
              <event>
                <sub_title>indigestion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="148"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="143"/>
              </event>
              <event>
                <sub_title>taste</sub_title>
                <description>participants disliked taste, worried about participation, withdrew from study</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="148"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="143"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Thomas W. Kensler, PhD</name_or_title>
      <organization>Johns Hopkins Bloomberg School of Public Health</organization>
      <phone>410-955-1292</phone>
      <email>tkensler@jhsph.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
